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Abstract
Background: Conflicting information exists regarding the association between hsCRP and the progression of early
stages of atherosclerosis. The purpose of the study was to investigate the association of high sensitiviy c-reactive
protein (hsCRP) along with major cardiovascular (CV) risk factors on early carotid atherosclerosis progression in a
large, population-based cohort study.
Methods: The study cohort included 839 young adults (aged 24 to 43 years, 70% white, 42% men) enrolled in
Bogalusa Heart Study, who in 2001-2002 attended baseline examination with measurements of CV risk factors.
Progression of carotid artery intima-media thickness (IMT) was assessed during a mean follow-up of 2.4 years.
Results: Carotid artery IMT progression rates were as follows: composite carotid artery = 9.2 ± 52 μm/y, common
carotid artery = 0.0 ± 51 μm/y, carotid bulb = 8.8 ± 103 μm/y, and internal carotid artery = 18.9 ± 81 μm/y.
Elevated baseline hsCRP, reflecting an inflammatory state, showed independent association with composite carotid
artery IMT progression. Increased age, systolic blood pressure, fasting glucose, LDL cholesterol, and current smoking
were other risk associates of carotid artery IMT progression in young adults, indicating an underlying burden on
the CV system by multiple risk factors.
Conclusion: In this population-based study, we observed independent categorical association of increased hsCRP
with carotid artery IMT progression in young adults. This study underlines the importance of assesssing hsCRP
levels along with smoking and traditional CV risk factor profiles in asymptomatic young adults.
Keywords: Carotid artery intima-media thickness progression, cardiovascular risk, c-reactive protein, epidemiology,
young adults
1. Background
Carotid artery intima-media thickness (IMT), as assessed
noninvasively by ultrasonography, is a useful measure of
preclinical atherosclerosis and has been found to predict
future risk for myocardial infarction, stroke, and death
from coronary heart disease. A change in carotid artery
IMT over time has been validated as a vascular marker
of the progression of atherosclerosis [1]. Such longitudi-
nal changes in carotid artery IMT provides further
pathophysiologic insights into atherogenesis. Childhood
risk factors were associated with carotid artery IMT in
young adulthood in the Bogalusa Heart Study [2], and
an increasing risk factor burden was associated with
increased aortic and coronary atherosclerosis found at
autopsy in young adults [3]. Although traditional CV
risk factors for atherosclerosis are well known [4,5],
increasing evidence implicates inflammation in the
pathogenesis of atherosclerosis and CV disease. Inde-
pendent association between elevated high sensitivity
c-reactive protein (hsCRP) and carotid artery IMT pro-
gression has revealed contradictory results [6-12]. High
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response associated with traditional CV risk factors or
reflect the causal role of inflammation in the initiation
and/or progression of atherosclerosis, further observa-
tions are needed.
As part of the Bogalusa Heart Study, a biracial (black-
white) community based epidemiological study of the
early natural history of cardiovascular (CV) disease, the
present study examines the relationships of baseline tradi-
tional CV risk factors and hsCRP to carotid artery IMT
progression in asymptomatic younger adults by race and
sex.
2. Methods
2.1.Study cohort and design
The Bogalusa Heart Study is a long-term epidemiologic
study of the early natural history of arteriosclerosis in chil-
dren and young adults from a semirural, biethnic (65%
white, 35% black) community in Bogalusa, Louisiana [13].
This report includes a cohort of 839 subjects (70% white,
42% men) who were examined in both the 2001-2002 sur-
vey (mean age, 36.6 ± 4.3 years; range, 24 to 43 years) and
the 2003-2005 survey (mean age, 39.0 ± 4.3 years; range,
26 to 46 years) for CV risk factors and carotid artery IMT.
All subjects in this study gave informed consent for exami-
nations. Study protocols were approved by the Institu-
tional Review Board of the Tulane University Health
Sciences Center.
2.2. General examinations
Standardized protocols were used by trained examiners
[14]. Height and weight were measured in triplicate, and
the mean values were used to calculate body mass index
(BMI = weight in kilograms divided by the square of the
height in meters) as a measure of overall obesity. Mean
waist circumference divided by height was used as an indi-
cator of visceral fatness. Right arm blood pressure was
measured in triplicate with mercury sphygmomanometers
by 2 trained observers while subjects were seated and
relaxed. The first and fifth Korotkoff phases were used to
determine systolic and diastolic blood pressure, respec-
tively; means of 6 replicate readings were used.
2.3. Laboratory analysis
Subjects were instructed to fast for 12 hours before
screening, and compliance was determined by interview
on the morning of examination. Plasma glucose was mea-
sured by a glucose oxidase method as part of the multiple
chemistry profile (SMA20) in the multichannel Olympus
Au-5000 Analyzer (Olympus, Lake Success, NY). A radio-
immunoassay kit was used to measure plasma insulin
(Phadebas insulin kit, Pharmacia Diagnostics, Piscataway,
NJ). Serum cholesterol and triglycerides were determined
enzymatically on the Hitachi 902 Automatic Analyzer
(Roche Diagnostics, Indianapolis, Ind.). Serum lipoprotein
cholesterols were analyzed by a combination of heparin-
calcium precipitation and agar-agarose gel electrophoresis
procedures. Plasma high sensitivity c-reactive protein
(CRP) was measured by latex particle-enhanced immuno-
turbidimetric assay on the Hitachi 902 Automatic Analy-
zer. Urinary albumin excretion was assessed on a morning
spot urine sample using an enzyme-linked immunosorbent
assay kit (Exocell, Philadelphia, Pa.). The laboratory is
being monitored by a surveillance program of the Centers
for Disease Control and Prevention, Atlanta, Ga. Intraclass
correlation coefficients, a measure of reproducibility of the
entire process from blood collection to data processing,
between the blind duplicate values (n = 103) were 0.98 for
total cholesterol, 0.99 for high-density lipoprotein (HDL)
cholesterol, and 0.98 for glucose.
2.4. Carotid ultrasonography
Trained sonographers performed ultrasound examina-
tions using the Toshiba Ultrasound instruments (Toshiba
SonoLayer SSH 160A and Toshiba Power Vision SSH-
380, Toshiba America Medical Systems, Tustin, Ca.) with
7.5-MHz linear array transducers. B-mode images were
recorded at the common catotid, carotid bulb (bifurca-
tion), and internal carotid arteries bilaterally according to
previously developed protocols for the Atherosclerosis
Risk in Communities study [15]. Images were recorded
on S-VHS 1/2” tapes and read centrally by certified read-
ers at the Division of Vascular Ultrasound Research,
Wake Forest University School of Medicine, using a
semiautomatic ultrasound image processing program
developed by the California Institute of Technology Jet
Propulsion Laboratory (Pasedena, Ca.) according to strict
protocols [16]. Previous readings from 2001-2002 were
accepted as baseline values. The mean of the maximum
carotid IMT readings of 3 right and 3 left far walls for
common, bulb, and internal segments was used. Images
were read at the same cardiac cycle, which was end dia-
stole. If bilateral images were not available, the value of
one side was used as the mean. The trained sonographers
were blinded to risk factor data. Reproducibility (mean
difference ± SD) of composite carotid artery IMT (aver-
age of the segmental maximum carotid IMT measure-
ments) in 141 subjects (69 from 2001-2002 survey and 72
from 2003-2005 survey) was 15.1 ± 84.4 μm for mean
maximum thickness corresponding with a 99% confi-
dence interval (CI) of -3.4 to 33.7 μm.
2.5. Statistical methods
All data analyses were performed using SPSS software
(SPSS Inc., Chicago, Il.). Insulin, triglycerides and urinary
albumin-creatinine ratio were log-transformed to improve
the normality of distribution; however, their mean values
in original scales are presented for description. Differences
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were tested by analysis of covariance models. Cardiovascu-
lar risk factors and carotid artery IMT at each survey were
described by mean ± SD values and contrasted by paired
t-test or McNemar test. The impact of the correlates on
composite carotid artery IMT progression was examined
by stepwise linear regression model in the total sample.
Composite carotid artery IMT progression was adjusted
for the baseline (2001-2002 survey) composite carotid
artery IMT and the risk model included baseline age, gen-
der, race, systolic and diastolic blood pressures, waist-
height ratio, fasting glucose, serum low-density lipoprotein
(LDL) cholesterol, HDL cholesterol, fasting triglycerides,
high-sensitivity c-reactive protein ≥ 2m g / la n ds m o k i n g
status with a p-value criteria of < 0.05.
3. Results
Table 1 shows the baseline and follow-up CV risk factors
at each survey by race and sex. Significant race differ-
ences were noted in both sexes for systolic and diastolic
blood pressures (whites < blacks), and the prevalence of
high sensitivity c-reactive protein ≥ 2m g / l( w h i t e s<
b l a c k s ) ;h o w e v e r ,t h er a c ed i f f e r e n c e si na g e( w h i t e s>
blacks), BMI (whites < blacks), waist-height ratio (whites
< blacks), glucose (whites < blacks), insulin (whites <
blacks), and triglycerides (whites > blacks) were signifi-
cant only in females. The race difference in HDL choles-
terol (whites < blacks), total cholesterol-HDL cholesterol
ratio (whites > blacks), and the prevalence of current
smoking (whites < blacks) were significant only in males.
Compared with women, men showed higher values of
systolic and diastolic blood pressures, serum triglycerides,
and total cholesterol-HDL cholesterol ratio; men had
lower BMI and higher prevalence of current smoking in
blacks only; however, men had lower HDL cholesterol
and the prevalence of high sensitivity c-reactive protein ≥
2 mg/l in whites only. Waist-height ratio and serum insu-
lin were higher white men > white women and black
women > black men. Significant increases in age (all
race-sex groups), BMI (whites), waist-height ratio (white
women), serum glucose (all except black men), LDL cho-
lesterol (white men), and HDL cholesterol (white
women); however significant decreses in diastolic blood
pressure and total cholesterol-HDL cholesterol ratio
(black men) were observed between 2 surveys. Significant
sex difference for BMI and waist-height ratio were no
longer evident in the follow-up survey, while glucose
showed a significant sex difference (white men > white
women).
Carotid IMT measurements and progression rates were
presented in Tables 2 and 3, respectively. At the baseline
survey, significant race differences were noted in both
sexes for common carotid artery IMT (whites < blacks);
however, the race differences in composite carotid artery
IMT (whites < blacks), and carotid bulb IMT (whites <
blacks) were significant only in females. Compared with
women, men showed higher values for composite, com-
mon, bulb, and internal carotid artery IMT. Significant
race differences for composite carotid artery and carotid
bulb IMT were no longer evident in the second survey.
Composite carotid artery (all except black men), carotid
bulb (white women), and internal carotid artery (all
except black men) IMT showed significant progression
between the two surveys (Table 2). Carotid IMT progres-
sion rates were as follows (Table 3): composite carotid
a r t e r y=9 . 2±5 2μm/y, common carotid artery = 0.0 ±
51 μm/y, carotid bulb = 8.8 ± 103 μm/y, and internal car-
otid artery = 18.9 ± 81 μm/y (Figure 1). Carotid artery
IMT progression rates did not differ significantly among
race-sex groups.
Baseline CV risk correlates of the composite carotid
artery IMT progression are presented in Table 4. Compo-
site carotid artery IMT progression was adjusted for the
baseline (2001-2002 survey) composite carotid artery IMT,
which showed a significant association with an unstandar-
dized difference of -0.296 ([95% CI between -0.353 and
-0.240], p < 0.001). Based on the magnitude of adjusted
difference in the total sample, increase in baseline age, sys-
tolic blood pressure, fasting glucose, prevalence of high
sensitivity c-reactive protein ≥ 2 mg/l, LDL cholesterol,
and prevalence of current smoking were, in that order,
associated with the composite carotid artery IMT
progression.
4. Discussion
In this large community population, we identified the
association of baseline traditional CV risks and hsCRP to
carotid artery IMT progression in young adults (24- to 43-
year old) over a 2.4-year period. The major finding was
that in addition to increase in baseline age, systolic blood
pressure, glucose, LDL cholesterol and the prevalence of
current smoking, increase in the prevalence of baseline
hsCRP ≥ 2 mg/l were associated with the composite caro-
tid artery IMT progression independent of other tradi-
tional CV risks. An earlier report from the Bogalusa Heart
Study demonstrated that smoking was the most consistent
predictor of carotid artery IMT progression in 336 young
men and women, who were screened in both 1995-1996
and 2000-2001 surveys, during an average follow-up of 5.8
years [4]. The prior reported composite and common car-
otid artery IMT progression rates of 17 μm/y and 16 μm/y
were much higher than the current composite and com-
mon of 9.2 μm/y and 0.0 μm/y in 839 young men and
women. The rate of progression over a 2.4-year period is
relatively short and may be responsible for the inability to
detect a significant progression of IMT in the common
carotid artery segment. Nevertheless, current report
expands the findings of this earlier article, in which the
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risk factors were investigated in a smaller sample of popu-
lation and relationship with hsCRP was not looked at.
A number of other large, prospective, and population-
based cohort studies have investigated the association
between hsCRP and carotid artery IMT progression. The
INVADE (intervention project of cerebrovascular events
and dementia in the community of Ebersberg) study [11]
have found an independent association between baseline
hsCRP and common carotid artery IMT progression after
2 years in elderly women but not in men. A considerable
number of other epidemiologic studies have found no
link between the increased baseline hsCRP levels with
carotid artery IMT progression. The Cardiovascular Risk
in Young Finns Study reported no association between
hsCRP in childhood (3 to 18 years of age) with carotid
artery IMT 21 years later [17]. The Rotterdam study [10]
reported no relation between hsCRP categories and
change in common carotid artery IMT during a mean
follow-up period of 6.4 years. On the other hand, the
same study also reported the relation of hsCRP and the
progression of carotid atherosclerosis by the finding of
independent and graded associations of hsCRP with the
extent and progression of carotid plaques and ankle-bra-
chial index in the elderly men and women ≥ 55 years of
age [10]. Similarly, Carotid Atherosclerosis Progression
Study [9] reported that hsCRP was not associated with
carotid artery IMT progression after 3 years in middle-
aged individuals. In our study, we have observed that
hsCRP ≥ 2 mg/l was an independent risk factor for early
composite carotid artery IMT progression for the whole
study population of young adults.
T h er o l eo fh s C R Pa sa na c u t ep h a s er e a c t a n to nt h e
progression of early atherosclerosis has not been clarified
in detail. High-sensitivity CRP levels might express the
inflammatory activity of the atherosclerotic lesion, but
Table 1 Baseline and follow-up cardiovascular risk characteristics of study cohort by race and sex
White Black P value*
Baseline survey (2001-2002) Men
(n = 266)
Women
(n = 324)
Men
(n = 85)
Women
(n = 164)
Race Sex
Age, years 37.0 ± 4.2
¶ 36.7 ± 4.2
¶ 36.9 ± 3.8
¶ 35.5 ± 4.7
¶ < 0.05
f NS
BMI, kg/m
2 29.2 ± 5.8
¶ 28.3 ± 7.2
¶ 29.8 ± 7.1 32.9 ± 9.1 < 0.001
f < 0.01
b
Waist/height 0.56 ± 0.08 0.53 ± 0.1
¶ 0.55 ± 0.09 0.59 ± 0.11 < 0.001
f < 0.05
Systolic blood pressure, mm Hg 118 ± 11 111 ± 11 129 ± 17 120 ± 16 < 0.001 < 0.001
Diastolic blood pressure, mm Hg 80 ± 8 75 ± 8 88 ± 13
‡ 80 ± 11 < 0.001 < 0.001
Fasting glucose, mg/dl 88 ± 24
¶ 84 ± 20
§ 91 ± 33 91 ± 35
§ < 0.05
f NS
Fasting insulin, μU/ml
† 12.8 ± 8.9 11.3 ± 8.3 12.2 ± 9.0 15.3 ± 12.1 < 0.001
f < 0.05
LDL cholesterol, mg/dl 130 ± 34
‡ 124 ± 33 124 ± 45 118 ± 33 NS NS
Fasting triglycerides, mg/dl
† 165 ± 129 118 ± 69 147 ± 126 88 ± 37 < 0.001
f < 0.001
HDL cholesterol, mg/dl 41 ± 12 51 ± 13
‡ 50 ± 13 51 ± 13 < 0.001
m < 0.001
w
Total cholesterol/HDL cholesterol 5.0 ± 1.4 4.0 ± 1.1 4.3 ± 1.6
‡ 3.8 ± 1.2 < 0.001
m < 0.05
High-sensitivity C-reactive protein ≥ 2 mg/l 32.6% 47.3% 47.1% 58.1% < 0.05 < 0.001
w
Current smoker 34.7% 27.2% 53.6% 32.2% < 0.01
m < 0.01
b
Follow-up survey (2003-2005)
Age, years 39.3 ± 4.2
¶ 39.1 ± 4.2
¶ 39.2 ± 3.8
¶ 37.9 ± 4.7
¶ < 0.05
f NS
BMI, kg/m
2 29.8 ± 6.2
¶ 28.8 ± 7.6
¶ 30.0 ± 7.5 33.6 ± 9.3 < 0.01
f NS
Waist/height 0.56 ± 0.08 0.54 ± 0.1
¶ 0.55 ± 0.1 0.59 ± 0.11 < 0.01
f NS
Systolic blood pressure, mm Hg 118 ± 12 111 ± 12 128 ± 17 121 ± 17 < 0.01 < 0.01
w
Diastolic blood pressure, mm Hg 80 ± 9 75 ± 8 86 ± 14
‡ 81 ± 12 < 0.05 < 0.01
w
Fasting glucose, mg/dl 94 ± 33
¶ 86 ± 17
§ 94 ± 25 96 ± 40
§ < 0.01
f < 0.01
w
LDL cholesterol, mg/dl 134 ± 39
‡ 125 ± 33 122 ± 40 119 ± 36 NS NS
Fasting triglycerides, mg/dl
† 174 ± 138 122 ± 69 142 ± 115 93 ± 51 < 0.01
f < 0.01
HDL cholesterol, mg/dl 42 ± 10 52 ± 13
‡ 51 ± 16 52 ± 13 < 0.01
m < 0.001
w
Total cholesterol/HDL cholesterol 5.0 ± 1.4 3.9 ± 1.1 4.0 ± 1.4
‡ 4.2 ± 1.4 < 0.01
m < 0.001
w
Current smoker 33.0% 28.7% 54.1% 32.1% < 0.01
m < 0.01
b
*Analysis of covariance (p value adjusted for age).
NS indicates p > 0.05;
f, females only;
m, males only;
b, blacks only;
w, whites only.
† Mean values are presented and their Log transformed values were used to calculate p values.
‡ p < 0.05 baseline survey vs follow-up survey.
§ p < 0.01 baseline survey vs follow-up survey.
¶ p < 0.001 baseline survey vs follow-up survey.
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function and progression of atherosclerotic lesions in the
early stages, and become more pronounced in advanced
stages with an important role in plaque vulnerability,
rapid progression of plaques, and thrombotic complica-
tions [18-20]. Considerable epidemiological evidence has
linked increased hsCRP levels with incresed risk of CV
events including myocardial infarction, stroke, death
from CV causes, coronary revascularization, or a combi-
nation of these in middle aged and elderly subjects
[9,21-28]. A number of these have suggested this associa-
tion is independent of traditional CV risk factors [21-27],
although others have found it attenuated when risk fac-
tors are controlled for [9,28]. A number of potential
mechanisms by which CRP may play a causal role in
atherosclerosis and CV disease have been implicated,
Table 2 Carotid artery IMT measurements in the baseline and follow-up surveys by race and sex
White Black P value*
Baseline survey (2001-2002) Men
(n = 266)
Women
(n = 324)
Men
(n = 85)
Women
(n = 164)
Race Sex
Composite CIMT, mm
† 0.851 ± 0.175
‡ 0.760 ± 0.123
§ 0.897 ± 0.180 0.807 ± 0.161
¶ < 0.01
f < 0.001
Common CIMT, mm
† 0.785 ± 0.136 0.704 ± 0.102 0.841 ± 0.156 0.770 ± 0.133 < 0.01 < 0.001
Bulb CIMT, mm
† 1.016 ± 0.311 0.907 ± 0.213
‡ 1.051 ± 0.352 0.943 ± 0.298 < 0.01
f < 0.01
Internal CIMT, mm
† 0.742 ± 0.211
§ 0.674 ± 0.183
§ 0.786 ± 0.213 0.703 ± 0.170
¶ NS < 0.01
Follow-up survey (2003-2005)
Composite CIMT, mm
† 0.867 ± 0.174
‡ 0.790 ± 0.162
§ 0.892 ± 0.223 0.836 ± 0.164
¶ NS < 0.01
w
Common CIMT, mm
† 0.781 ± 0.143 0.711 ± 0.120 0.818 ± 0.171 0.775 ± 0.148 < 0.01
f < 0.001
w
Bulb CIMT, mm
† 1.032 ± 0.298 0.942 ± 0.280
‡ 1.058 ± 0.361 0.964 ± 0.256 NS < 0.05
w
Internal CIMT, mm
† 0.793 ± 0.232
§ 0.711 ± 0.218
§ 0.820 ± 0.255 0.762 ± 0.198
¶ NS < 0.05
w
*Analysis of covariance (p value adjusted for age).
NS indicates p > 0.05;
f, females only;
w, whites only.
† Mean values are presented and their Log transformed values were used to calculate p values.
‡ p < 0.05 baseline survey vs follow-up survey.
§ p < 0.01 baseline survey vs follow-up survey.
¶ p < 0.001 baseline survey vs follow-up survey.
Table 3 Carotid artery IMT progression rates
Site Race and sex N Mean ΔCIMT
μm/year
95% CI, μm/year
Lower Upper
Composite CIMT* All 695 9.2 5.3 13.0
White men 231 5.7 -1.0 12.4
Black men 70 2.8 -12.0 17.5
White women 266 11.3 4.9 17.7
Black women 128 14.5 6.5 22.3
Common CIMT* All 799 0.0 -3.5 3.5
White men 256 -0.8 -6.2 4.7
Black men 84 -9.7 -24.3 4.9
White women 302 2.6 -2.5 7.6
Black women 157 1.5 -7.9 11.0
Bulb CIMT* All 768 8.8 1.4 16.1
White men 247 3.3 -9.6 16.1
Black men 79 6.2 -20.1 32.5
White women 297 13.2 1.4 25.1
Black women 145 10.3 -5.3 25.8
Internal CIMT* All 706 18.9 13.0 24.9
White men 235 18.2 7.9 28.4
Black men 71 14.7 -7.8 37.2
White women 267 15.6 6.1 25.1
Black women 133 29.2 15.9 42.5
*Analysis of variance p > 0.05 among race-sex groups.
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tic lesion [29], intimal growth [30], and endothelial dys-
function [19,31].
As might be expected, this study identified baseline
predictors of longitudinal carotid artery IMT progression,
it is an association study and it is subject to selection
bias. CRP is produced in the liver and its concentration is
increased by infections that show no relationship to
atherosclerosis, as well as by malignancy. Intima-media
thickening reflects early atherosclerotic change as well as
Table 4 Baseline independent cardiovascular risk correlates of the composite carotid artery IMT progression in young
adults
Univariate Associations
(Unadjusted)
Multivariable Model Following Stepwise Selection
(Adjusted for Baseline IMT)
Variables Univariate
Correlations
p value Unstandardized difference* 95% CI Standardized difference* p value
Age, years 0.199 < 0.001 0.006 0.004 - 0.008 0.208 < 0.001
Systolic blood pressure, mm Hg 0.165 < 0.001 0.002 0.001 - 0.002 0.171 < 0.001
Fasting glucose, mg/dl 0.129 < 0.001 0.001 0.000 - 0.001 0.126 < 0.01
hsCRP ≥ 2 mg/l 0.110 < 0.001 0.025 0.008 - 0.043 0.103 < 0.01
LDL cholesterol, mg/dl 0.085 < 0.01 0.000 0.000 - 0.001 0.088 < 0.05
Current smoker 0.091 < 0.05 0.021 0.003 - 0.039 0.084 < 0.05
Baseline IMT (microns) (-0.369) < 0.001 (-0.296) (-0.353) - (-0.240) (-0.405) < 0.001
Gender (women vs men) 0.035 0.37 0.008 (-0.011) - 0.027 0.032 0.42
Race (black vs white) (-0.025) 0.51 (-0.01) (-0.031) - 0.011 -0.038 0.35
Diastolic blood pressure, mmHg (-0.022) 0.57 0.000 (-0.002) - 0.001 -0.033 0.65
Waist-height ratio (-0.002) 0.46 0.008 (-0.104) - 0.121 0.006 0.88
HDL cholesterol, mg/dl 0.021 0.6 0.000 (-0.001) - 0.001 0.014 0.72
Fasting triglycerides, mg/dl
† (-0.021) 0.59 (-0.004) (-0.022) - 0.014 (-0.019) 0.65
Baseline adjusted stepwise linear regression model included age, gender, race, systolic and diastolic blood pressures, waist-height ratio, fasting glucose, serum
low density lipoprotein cholesterol, high density lipoprotein cholesterol, fasting triglycerides
†, high-sensitivity C-reactive protein ≥ 2 mg/l and smoking status.
*Unstandardized and standardized differences in mean composite carotid artery IMT progression.
† Log transformed value was used in the model.
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was insufficient to investigate associations with more
advanced atherosclerosis in our population. Restricting
measurements of IMT to the common carotid artery seg-
ment has been justified in other studies by greater repro-
ducibility of measurements from this site and the
difficulty in obtaining measurements from the bifurcation
or the internal carotid artery in some populations. In the
present study, 87% of all subjects had valid IMT mea-
surements from all segments. Protocols that involve addi-
tional segments have several advantages [5]. First,
progression is more prominent in the bifurcation and the
internal carotid artery. Thus, including these sites may
provide the most sensitive and statistically powerful
assessment of atherosclerosis progression. Yet, aggregat-
ing data across segments may provide measures that are
stable and less sensitive to measurement error.
Some methodologic limitations must be taken into
account in the interpretation of results. The rate of pro-
gression over a 2.4-year period is relatively short and com-
bined with measurement errors, which could be related in
part to two different ultrasound machine recordings
between surveys, may be responsible for the inability to
detect a significant progression of IMT in the common
carotid artery segment. Nevertheless, we have identified
associations between traditional CV risk factors, hsCRP
and composite carotid artery IMT in cross sectional stu-
dies in this population. Longer-term follow-up should
increase the power to detect other associations and reveal
race and gender differences.
Conclusion
In a prospective, population-based study, we observed
independent categorical association of increased hsCRP
and multiple conventional risk factors including smoking
with carotid artery IMT progression in young adults.
This study underlines the importance of assesssing CV
risk factor profiles and hsCRP level in young adults.
These observations demonstrate that risk factors are
associated with the progression of subclinical athero-
sclerosis even in young individuals who are at low risk
for cardiac events. These observations reflect on the CV
risk burden over time by risk factors including inflamma-
tion and smoking.
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